Variant report
Variant | nsv590965 |
---|---|
Chromosome Location | chr3:89709444-89737883 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570914766 | chr3:89710204-89710205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533406954 | chr3:89710243-89710244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551698126 | chr3:89710277-89710278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs200458390 | chr3:89710330-89710331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570228162 | chr3:89710403-89710404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537277618 | chr3:89710475-89710476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181014040 | chr3:89710483-89710484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547081146 | chr3:89710509-89710510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567621818 | chr3:89710540-89710541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576522306 | chr3:89710560-89710561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535143211 | chr3:89710735-89710736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11916699 | chr3:89710736-89710737 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs114232634 | chr3:89710755-89710756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs578075739 | chr3:89710778-89710779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185810162 | chr3:89710849-89710850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557336961 | chr3:89710850-89710851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575373340 | chr3:89710853-89710854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374294521 | chr3:89710896-89710897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542490979 | chr3:89710903-89710904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559039590 | chr3:89710905-89710906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369185711 | chr3:89711001-89711002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561151877 | chr3:89711071-89711072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568483741 | chr3:89711140-89711141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34944155 | chr3:89711143-89711144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149979308 | chr3:89711161-89711162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187515709 | chr3:89712413-89712414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143905245 | chr3:89712469-89712470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192536177 | chr3:89712539-89712540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528679778 | chr3:89712556-89712557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547179490 | chr3:89712559-89712560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75203463 | chr3:89712629-89712630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368028619 | chr3:89712672-89712673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565501536 | chr3:89712679-89712680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184763803 | chr3:89712710-89712711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568690322 | chr3:89724844-89724845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377572410 | chr3:89724871-89724872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370939898 | chr3:89724934-89724935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374218830 | chr3:89724949-89724950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537018754 | chr3:89724950-89724951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113875144 | chr3:89724990-89724991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532893482 | chr3:89724991-89724992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536006510 | chr3:89725015-89725016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148335196 | chr3:89725044-89725045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545015045 | chr3:89725045-89725046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79347877 | chr3:89725064-89725065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533659267 | chr3:89725097-89725098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558512783 | chr3:89725101-89725102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576807244 | chr3:89725133-89725134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556810743 | chr3:89725139-89725140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79695793 | chr3:89725171-89725172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 19547694 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:89710200-89711200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr3:89710600-89711000 | Enhancers | Adipose Nuclei | Adipose |
3 | chr3:89712400-89712800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr3:89724800-89725400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr3:89725400-89726400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr3:89726400-89727000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr3:89731200-89732200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr3:89734600-89735000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr3:89734800-89735400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr3:89735000-89735400 | Enhancers | Brain Germinal Matrix | brain |